Finance

Beta
Roʻyxatlar
Aksiyalar sektorlari
Belgilar
Belgilar
Narxi
Oʻzgartirishlar
Dinamika (%)
Trend
Avvalgi yopilish narxi
Ochish
Yuqori
Past
Hajmi
Bozor kapitali
SIXB
Materials
SIXB
Materials
SIXB
-0,71%
1 092,80
-7,77
-0,71%
—1 100,571 098,941 103,801 084,24——
SIXC
Communications
SIXC
Communications
SIXC
-0,07%
604,74
-0,41
-0,07%
—605,15605,15606,69602,76——
SIXE
Energy
SIXE
Energy
SIXE
+1,64%
1 214,80
+19,61
+1,64%
—1 195,191 204,711 221,691 204,71——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,88%
1 724,57
-15,34
-0,88%
—1 739,911 734,501 734,501 710,67——
SIXM
Financials
SIXM
Financials
SIXM
+0,14%
639,43
+0,87
+0,14%
—638,56640,21645,32638,69——
SIXR
Staples
SIXR
Staples
SIXR
+0,91%
839,15
+7,58
+0,91%
—831,57840,48844,16834,54——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1,06%
215,62
+2,26
+1,06%
—213,36213,36215,79212,77——
SIXT
Technology
SIXT
Technology
SIXT
-1,69%
3 179,52
-54,66
-1,69%
—3 234,183 171,863 195,363 145,46——
SIXU
Utilities
SIXU
Utilities
SIXU
+0,13%
936,91
+1,26
+0,13%
—935,65937,31941,44933,16——
SIXV
Health care
SIXV
Health care
SIXV
+0,24%
1 452,77
+3,51
+0,24%
—1 449,261 454,771 462,651 447,95——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0,72%
2 365,18
-17,27
-0,72%
—2 382,452 371,192 380,452 362,86——
4502:TYO
Takeda Pharmaceutical Co Ltd
5 289,00 JP¥
+1,36%
(+71,00) 1K
28-apr, 15:30:00 (GMT+9)  ·   JPY
Barcha belgilar
BelgiNarxiOʻzgartirishlarDinamika (%)
4502 tikeri uchun statistika yaratilmoqda...
Ochish
5 292 JP¥
Yuqori
5 295 JP¥
Past
5 224 JP¥
Bozor kapitali
8,42 trln
Oʻrtacha hajm
4,37 mln
Hajmi
3,36 mln
Dividend
3,74%
Choraklik dividendlar
49 JP¥
Eks-dividend sanasi
29-sen, 2025
P/E koeffitsiyenti
73,20
52 haftalik eng yuqori
6 033 JP¥
52 haftalik eng past
4 000 JP¥
Aksiya boʻyicha daromad
72 JP¥
Muomaladagi aksiyalar
784,48 mln
Xodimlar soni
47 ming
Yangiliklar
Internetdagi manbalardan
Profil
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. Wikipedia
Takeda Pharmaceutical Co Ltd haqida
CEOChristophe Weber | Christophe Weber
Xodimlar soni47,5 ming
Asos solingan12-iyn, 1781
Bosh ofislar-
Sektor-
Veb-sayttakeda.com
Oxirgi hisobot
29-yan, 2026
Moliya davri
Ch.3 2026
Normallashtirilgan EPS / Taxminiy
-/ -JPY
Daromad / Taxminan
1,19 trln/ (1,20 trln taxm.)JPY
Q3 2026 uchun tushumlar hisoboti
Tushumlar hisoboti kutilmoqda
QisqachaOxirgi yangiliklar va hisobotlar sarhisobi
Avvalgi hisobotlarBarcha qiymatlar – JPY
Loading Previous Earnings...
Daromad hisoboti
Daromad
Sof foyda
Barcha qiymatlar – JPY
mar, 2025
iyn, 2025
sen, 2025
dek, 2025
Daromad
1,05 trln
1,11 trln
1,11 trln
1,19 trln
Sotilgan mahsulotning tannarxi
373,28 mlrd
384,68 mlrd
380,06 mlrd
401,15 mlrd
Daromad narxi
373,28 mlrd
384,68 mlrd
380,06 mlrd
401,15 mlrd
Tadqiqot va ishlanmalarga xarajatlar
216,01 mlrd
143,89 mlrd
161,48 mlrd
175,23 mlrd
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar
-
-
-
-
Tijoriy, umumiy va maʼmuriy xarajatlar
295,83 mlrd
255,88 mlrd
253,55 mlrd
282,78 mlrd
Operatsion xarajatlar
557,10 mlrd
535,14 mlrd
562,57 mlrd
661,30 mlrd
Jami operatsion xarajatlar
930,38 mlrd
919,82 mlrd
942,63 mlrd
1,06 trln
Operatsion daromad
123,02 mlrd
186,86 mlrd
170,17 mlrd
129,25 mlrd
Boshqa nooperatsion daromad
-24,86 mlrd
-77,96 mlrd
77,96 mlrd
-294,52 mlrd
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar
-107,30 mlrd
150,63 mlrd
28,17 mlrd
133,86 mlrd
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno
100,18 mlrd
152,93 mlrd
128,86 mlrd
114,17 mlrd
Daromad soligʻi boʻyicha xarajat
-4,20 mlrd
26,35 mlrd
39,90 mlrd
30,13 mlrd
Amaldagi soliq stavkasi
3,92%
17,49%
141,64%
22,51%
Boshqa operatsion xarajatlar
-91,26 mlrd
6,03 mlrd
16,12 mlrd
67,13 mlrd
Sof foyda
-103,16 mlrd
124,24 mlrd
-11,80 mlrd
103,64 mlrd
Sof foyda marjasi
-9,79%
11,23%
-1,06%
8,70%
Har bir aksiya foydasi
-
-
-
-
Foizlar va investitsiyalardan olingan daromadlar
9,85 mlrd
73,76 mlrd
43,92 mlrd
278,65 mlrd
Foizlarni toʻlash xarajatlari
-7,82 mlrd
-29,20 mlrd
-161,10 mlrd
-
Foizlarni toʻlash boʻyicha sof xarajatlar
2,03 mlrd
44,56 mlrd
-117,18 mlrd
278,65 mlrd
Amortizatsiya ajratmalari
-
-
-
-
EBITDA
221,72 mlrd
368,50 mlrd
355,15 mlrd
182,70 mlrd
Aktivlarni sotishdan olingan foyda yoki zarar
-2,39 mlrd
-17,32 mlrd
303,00 mln
358,00 mln
AI kontentda xatolar boʻlishi mumkin. Batafsil
YordamFikr-mulohazaMaxfiylikShartlarMajburiyatlardan voz kechish

Tahlil

Vazifalarim
Hali vazifa yaratmagansiz
Vazifalaringiz shu yerda chiqadi. Vazifalarni rejalashtiring va Google Finance xizmatidan foydalaning.
Andozalar
Kuzatuv roʻyxati brifingi
Kuzatuv roʻyxatining kunlik bozor oldidan tahlili
Kelgusi tushumlar
Hafta ichida kelgusi tushum hisobotlari
Anomal volatillik va hajm
Bugun erta ogohlantirish: volatillik va hajm
AI kontentda xatolar boʻlishi mumkin. Batafsil
YordamFikr-mulohazaMaxfiylikShartlarMajburiyatlardan voz kechish